A cost analysis of functional bowel disorders in Iran

Roshandel, Delnaz; Rezailashkajani, Mohammadreza; Shafaee, Sepideh; Zali, Mohammad Reza

doi:10.1007/s00384-006-0226-2

Cited by 25 publications

(23 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…23 It has been estimated that absenteeism and presenteeism due to IBS amounts to an annual loss per patient of $748 in Canada (1996), 24 US$335 in UK 25 and $812 in Iran. 26 In 2005, a US banking organisation calculated that their total productivity loss attributable to IBS was $7737 per patient annually irrespective of bowel habit subtype. 27 In Denmark, the median annual cost due to absenteeism was $1508 per IBS patient.…”

Section: The Burden Of Ibs On Healthcare Systemsmentioning

confidence: 99%

The global impact of IBS: time to think about IBS-specific models of care?

Corsetti

Whorwell

2017

Therap Adv Gastroenterol

View full text Add to dashboard Cite

Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal (GI) disorder that can significantly erode the quality of life (QoL) of sufferers and places a major cost burden on healthcare services. This paper reviews the literature on the impact of IBS on healthcare services and society, including a recent report on the subject, in order to formulate a plan for the future. A completely different model of care for these patients is recommended based on this review and the experience of the two authors who have been treating patients with functional GI disorders for 20 and 35 years, respectively.

show abstract

Section: The Burden Of Ibs On Healthcare Systemsmentioning

confidence: 99%

The global impact of IBS: time to think about IBS-specific models of care?

Corsetti

Whorwell

2017

Therap Adv Gastroenterol

View full text Add to dashboard Cite

show abstract

“…Annual treatment cost per patient estimated in other countries included United Kingdom estimates of between GBP316 and GBP906[25,26], Canadian estimate of USD259[20], and Norwegian estimate of NOK954 and NOK14854[27]. Likewise, two Asian studies estimated the costs of IBS to be USD155 million in Korea nationally[28], and the annual cost per patient as USD90 in Iran[29]. Generally, the costs of primary care form a large part of total burden in IBS[18].…”

Section: Introductionmentioning

confidence: 99%

Economic burden of irritable bowel syndrome in China

Zhang

Xiang

et al. 2016

WJG

View full text Add to dashboard Cite

AIMTo estimate annual direct and indirect costs for patients diagnosed with irritable bowel syndrome (IBS) and subtypes.METHODSPatients completed a standardized questionnaire concerning usage of healthcare resources, travel costs, meals, and productivity loss of patients when seeking treatment for IBS. Total annual costs per patient were calculated as the sum of direct (including medical and nonmedical) and indirect costs. Total annual costs per patient among various IBS subtypes were compared. Analysis of variance and bootstrapped independent sample t-tests were performed to determine differences between groups after controlling for IBS subtypes.RESULTSA total of 105 IBS patients (64.80% female), mean age of 57.12 years ± 10.31 years), mean disease duration of 4.31 years ± 5.40 years, were included. Total annual costs per patient were estimated as CNY18262.84 (USD2933.08). Inpatient and outpatient healthcare use were major cost drivers, accounting for 46.41%and 23.36% of total annual costs, respectively. Productivity loss accounted for 25.32% of total annual costs. The proportions of direct and indirect costs were similar to published studies in other countries. Nationally, the total costs of managing IBS would amount to CNY123.83 billion (USD1.99 billion). Among the IBS subtypes, total annual costs per patient of IBS-M was highest at CNY18891.18 (USD3034). Furthermore, there was significant difference in productivity loss among IBS subtypes (P = 0.031).CONCLUSIONIBS imposes a huge economic burden on patients and healthcare systems, which could account for 3.3% of the total healthcare budget for the entire Chinese nation. More than two-thirds of total annual costs of IBS consist of inpatient and outpatient healthcare use. Among the subtypes, IBS-M patients appear to have the greatest economic burden but require further confirmation.

show abstract

“…This may be because bloating is reported to be bothersome and annoying, unlike abdominal pain, which is perceived as an alarm sign and life threatening (12). However, the direct and indirect costs of bloating approach $260 per person per year in Iran in the general population; it imposes a greater economic burden than many other clinical conditions (13).…”

Section: Introductionmentioning

confidence: 99%

Risk factors of bloating and its association with common gastrointestinal disorders in a sample of Iranian adults

Keshteli

Daneshpajouhnejad

Adibi³

2017

Turk J Gastroenterol

View full text Add to dashboard Cite

Background/Aims: Bloating is an unpleasant but common gastrointestinal symptom that is experienced by many people at some stage in their lives. The current survey was conducted to investigate the epidemiology and risk factors of bloating and functional bloating (FB). In addition, we aimed to assess the association between bloating and functional gastrointestinal disorders (FGIDs). Materials and Methods: In this cross-sectional study, the self-administered modified Rome III questionnaire was used to assess gastrointestinal symptoms and FGIDs. Severity of bloating, demographic and anthropometric measurements, physical activity level, psychological distress, and depression and anxiety were also assessed. Results: Among the 4763 participants, 52.9% reported having experienced bloating at least occasionally in the past three months (among which 14.1% had severe or very severe symptoms); 19.7% of subjects were found to have FB. After adjusting for multiple variables, female gender, university degree, obesity, and anxiety were associated with both bloating and FB, while depression and psychological distress were only associated with bloating. The positive predictive value and negative predictive value of bloating for the diagnosis of functional bowel disorder were 92.9% and 80.1%, respectively. Conclusion: Bloating and FB are highly prevalent in the study population. We also identified several demographic, psychological, and lifestyle-related risk factors of bloating in this population. Keywords: Bloating, functional bloating, functional gastrointestinal disorders, Iran, epidemiology Original Article retention, weak anterior wall muscle tone, abnormal gut microflora, inflammation, and altered bowel tonic and phasic motility, none of these has been scientifically proven (3,14). However, studies have shown both increased intestinal gas accumulation and delayed gas transit to be important causes of bloating. Distorted perception and visceral hyperalgesia may also play a role in some patients (2,3,5,14).Physical exercise accelerates gut transit and thus reduces bloating; however, studies on healthy subjects found that physical activity accelerated gas transit but did not affect bloating. The relationship between physical activity and bloating remains unclear (5). Obesity is also an established risk factor for FGIDs; however, data regarding its effects on bloating contain discrepancies (14). Psychological therapies have also been found to be useful in improving bloating and several other FGIDs; however, it remains unclear whether an actual relationship exists between bloating and psychosocial distress (2). Studies have also evaluated the associations of bloating with smoking, marital status, age, and education level (4,5,7); however, data confirming the associations of these variables is limited.The prevalence of bloating, as a symptom, is dramatically higher in subjects who suffer from other FGIDs, notably irritable bowel syndrome (IBS) (4). Studies have shown that more than two thirds of IBS patients may complain ...

show abstract

A cost analysis of functional bowel disorders in Iran

Abstract: As proven in developed countries, FBD and especially IBS seem to put a heavy burden on the economy of a developing country like Iran. Further population-based studies are needed for more precise estimations.

Cited by 25 publications

References 24 publications

The global impact of IBS: time to think about IBS-specific models of care?

The global impact of IBS: time to think about IBS-specific models of care?

Economic burden of irritable bowel syndrome in China

Risk factors of bloating and its association with common gastrointestinal disorders in a sample of Iranian adults

Contact Info

Product

Resources

About